HIV infection and the incidence of malaria among HIV-exposed children from Tanzania

Journal of Infectious Diseases

Volumn 205, Issue 10, 2012, Pages 1486-1494

  Ezeamama, Amara E ^a   Spiegelman, Donna ^b   Hertzmark, Ellen ^b   Bosch, Ronald J ^b,c   Manji, Karim P ^d   Duggan, Christopher ^a,e   Kupka, Roland ^a,f   Lo, Melanie W ^g   Okuma, James O ^a   Kisenge, Rodrick ^d   Aboud, Said ^d,h   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Epidemiology ^*  (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d SCHOOL OF MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f Regional Office for West and Central Africa   (Senegal)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; NEVIRAPINE; VIRUS DNA;

ARTICLE; BLOOD SMEAR; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFECTION RISK; INFECTION SENSITIVITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; NEWBORN; PARASITEMIA; POLYMERASE CHAIN REACTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; TANZANIA;

ADULT; ANTI-HIV AGENTS; ANTIMALARIALS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALARIA; MALE; PARASITEMIA; PLASMODIUM; PREGNANCY; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TANZANIA; YOUNG ADULT;

EID: 84860366317     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis234     Document Type: Article

References (30)

1. UN Joint Programme on HIV/AIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic: 2010. December 2010, ISBN 978-92-9173-871-7, available at: http://www.unhcr.org/refworld/docid/4cfca9c62.html. Accessed 3 April 2012.
2. WHO. World Malaria Report: 2010. Geneva, Switzerland: World Health Organization, 2011.
3. Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS 2006; 20:1993-2004.
4. Kamya MR, Gasasira AF, Yeka A, et al. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis 2006; 193:9-15.
5. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science 2006; 314:1603-6.
6. Patnaik P, Jere CS, Miller WC, et al. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis 2005; 192: 984-91.
7. Whitworth J, Morgan D, Quigley M, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet 2000; 356: 1051-6.
8. Mermin J, Lule J, Ekwaru JP, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004; 364:1428-34.
9. Colebunders R, Bahwe Y, Nekwei W, et al. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect 1990; 21:167-73.
10. Good MF, Doolan DL. Immune effector mechanisms in malaria. Curr Opin Immunol 1999; 11:412-9.
11. Muller O, Moser R. The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. Trans R Soc Trop Med Hyg 1990; 84:336-8.
12. Nguyen-Dinh P, Greenberg AE, Mann JM, et al. Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire. Bull World Health Organ 1987; 65:607-13.
13. Kalyesubula I, Musoke-Mudido P, Marum L, et al. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. Pediatr Infect Dis J 1997; 16:876-81.
14. Villamor E, Fataki MR, Mbise RL, Fawzi WW. Malaria parasitaemia in relation to HIV status and vitamin A supplementation among preschool children. Trop Med Int Health 2003; 8:1051-61.
15. Malamba S, Hladik W, Reingold A, et al. The effect of HIV on morbidity and mortality in children with severe malarial anaemia. Malar J 2007; 6:143.
16. Otieno RO, Ouma C, Ong'echa JM, et al. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 2006; 20:275-80.
17. Renia L, Potter SM. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol 2006; 28:589-95.
18. TCAIDS. Tanzania Commission for AIDS: UNGASS Country Progress Report Tanzania Mainland. Dar es Salaam, Tanzania: Tanzania Commission on AIDS. 2008.
19. Dongus S, Nyika D, Kannady K, et al. Urban agriculture and Anopheles habitats in Dar es Salaam, Tanzania. Geospat Health 2009; 3:189-210.
20. Geissbuhler Y, Kannady K, Chaki PP, et al. Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PLoS One 2009; 4:e5107.
21. National Bureau of Statistics (NBS) [Tanzania] and ORC Macro. Tanzania Demographic and Health Survey 2004-05. Dar es Salaam, Tanzania: National Bureau of Statistics and ORC Macro, 2008.
22. Erdman LK, Kain KC. Molecular diagnostic and surveillance tools for global malaria control. Travel Med Infect Dis 2008; 6:82-99.
23. Tangpukdee N, Duangdee C, Wilairatana P, Krudsood S. Malaria diagnosis: a brief review. Korean J Parasitol 2009; 47:93-102.
24. Aboud S, Urassa W, Lyamuya E, Mhalu F, Biberfeld G. Evaluation of HIV antibody and antigen/antibody combination ELISAs for use in an alternative confirmatory HIV testing strategy in Dar es Salaam, Tanzania. J Virol Methods 2006; 135:192-6.
25. Callens SF, Kitetele F, Lusiama J, et al. Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility. BMC Infect Dis 2008; 8:31.
26. Zeger SL, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med 1992; 11:1825-39.
27. World Health Organization (WHO). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission [WHO/MAL/96.1077]. Geneva: WHO, 1996.
28. Vora N, Homsy J, Kakuru A, et al. Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 2010; 55:253-61.
29. Sandison TG, Homsy J, Arinaitwe E, et al. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ 2011; 342:d1617.
30. Republic of Tanzania. 2002. National Malaria Medium Term Strategic Plan, 2002-2007. 2003;2008.